Frequently Bought Together
rProtein A MagBeads (IP Grade) consist of 200 nm superparamagnetic beads covalently coupled with a high density of recombinant Protein A on the bead surface. The nanoscale beads offer an exceptionally large specific surface area, providing more binding sites, lower bead consumption, and a low non-specific binding rate.
The recombinant Protein A ligand is well suited for binding mouse IgG2a, IgG2b, and IgA, rabbit IgG, as well as human IgG1, IgG2, and IgG4. This product is broadly applicable to immunoprecipitation (IP) and co-immunoprecipitation (CoIP) from samples such as cell lysates, cell culture supernatants, serum, ascites, and other antigen samples.
Features
High binding capacity: >0.9 mg human IgG per mL of beads, supported by the large specific surface area of 200 nm silica-based magnetic beads.
Low non-specific adsorption: Nano-scale magnetic beads provide more binding sites and require lower bead consumption.
Broad antibody compatibility: Recombinant Protein A binds mouse IgG2a, IgG2b, and IgA, rabbit IgG, and human IgG1, IgG2, and IgG4.
Components
|
Components No. |
Name |
36418ES03 |
36418ES08 |
|
36418 |
rProtein A MagBeads (IP Grade) |
1 mL |
5 mL |
Specifications
|
Matrix |
Silica-based magnetic beads |
|
Ligand |
Recombinant Protein A |
|
Binding Capacity |
> 0.9 mg human IgG per mL of beads(hIgG /mL) |
|
Particle Size |
200 nm |
|
Bead Concentration |
10 mg/mL |
|
Application |
IP, CoIP, ChIP, RIP, etc. |
Application
IP, CoIP, ChIP, and RIP
Storage
FAQ
Citations
Documents
Applications
Du kan også lide
Forespørgsel
FAQ
Produktet er kun til forskningsformål og er ikke beregnet til terapeutisk eller diagnostisk brug hos mennesker eller dyr. Produkter og indhold er beskyttet af patenter, varemærker og ophavsrettigheder ejet af Yeasen Biotechnology. Varemærkesymboler angiver oprindelseslandet, ikke nødvendigvis registrering i alle regioner.
Visse applikationer kan kræve yderligere tredjeparts intellektuelle ejendomsrettigheder.
Yeasen er dedikeret til etisk videnskab og mener, at vores forskning bør adressere kritiske spørgsmål og samtidig sikre sikkerhed og etiske standarder.